QUYNH CHAU: Open Payments
NPI 1871982546 · NORMAN, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$199 in 12 payments from 8 companies in 2025. Trend: 2023 $521 · 2024 $546 · 2025 $199
Food & beverage: $199
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $71 |
| ABBVIE INC. | 2 | $29 |
| Novo Nordisk Inc | 1 | $21 |
| Alkermes, Inc. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| Amgen Inc. | 1 | $15 |
| Exact Sciences Corporation | 1 | $15 |
Products named: AIRSUPRA, Rybelsus, ARISTADA, CAPLYTA, BREZTRI, UBRELVY, REXULTI, OTEZLA.
Industry payments across OK — which companies pay providers there.
